Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of bla CMY-2 and resistance to piperacillin/tazobactam in Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 2, 2012, Pages 339-345

  Kurpiel, Philip M ^a   Hanson, Nancy D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lactamases; AmpC; IncI1

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; GENE DOSAGE; GENETIC ASSOCIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POINT MUTATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DNA REPLICATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE DOSAGE; HUMANS; PENICILLANIC ACID; PIPERACILLIN; PLASMIDS; POINT MUTATION; RNA, ANTISENSE;

EID: 84855846008     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr479     Document Type: Article

References (31)

1. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type b-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
2. Bauernfeind A, Stemplinger I, Jungwirth R et al. Characterization of the plasmidic b-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 1996; 40: 221-4.
3. Baudry PJ, Mataseje L, Zhanel GG et al. Characterization of plasmids encoding CMY-2 AmpC b-lactamases from Escherichia coli in Canadian intensive care units. Diagn Microbiol Infect Dis 2009; 65: 379-83.
4. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53: 2227-38.
5. Liu YF, Yan JJ, Ko WC et al. Characterization of carbapenem-nonsusceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 2008; 61: 1020-3.
6. Mammeri H, Guillon H, Eb F et al. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmidborne AmpC b-lactamases. Antimicrob Agents Chemother 2010; 54: 4556-60.
7. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-64.
8. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
9. Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: e56-93.
10. Dinubile MJ, Friedland I, Chan CY et al. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005; 24: 443-9.
11. Lai CC, Wang CY, Chu CC et al. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother 2011; 66: 1374-82.
12. Hama C, Takizawa T, Moriwaki H et al. Organization of the replication control region of plasmid ColIb-P9. J Bacteriol 1990; 172: 1983-91.
13. Tanaka K, Sakai H, Honda Y et al. Structural and functional features of cis-acting sequences in the basic replicon of plasmid ColIb-P9. Nucleic Acids Res 1992; 20: 2705-10.
14. Shiba K, Mizobuchi K. Posttranscriptional control of plasmid ColIb-P9 repZ gene expression by a small RNA. J Bacteriol 1990; 172: 1992-7.
15. Asano K, Mizobuchi K. Copy number control of IncIa plasmid ColIb-P9 by competition between pseudoknot formation and antisense RNA binding at a specific RNA site. EMBO J 1998; 17: 5201-13.
16. Asano K, Mizobuchi K. An RNA pseudoknot as the molecular switch for translation of the repZ gene encoding the replication initiator of IncIa plasmid ColIb-P9. J Biol Chem 1998; 273: 11815-25.
17. Praszkier J, Pittard AJ. Control of replication in I-complex plasmids. Plasmid 2005; 53: 97-112.
18. Asano K, Niimi T, Yokoyama S et al. Structural basis for binding of the plasmid ColIb-P9 antisense Inc RNA to its target RNA with the 5'-rUUGGCG-3' motif in the loop sequence. J Biol Chem 1998; 273: 11826-38.
19. Nikoletti S, Bird P, Praszkier J et al. Analysis of the incompatibility determinants of I-complex plasmids. J Bacteriol 1988; 170: 1311-8.
20. Jacoby GA, Sutton L. β-lactamases and β-lactam resistance in Escherichia coli. Antimicrob Agents Chemother 1985; 28: 703-5.
21. Reisbig MD, Hossain A, Hanson ND. Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. J Antimicrob Chemother 2003; 51: 1141-51.
22. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
23. Moland ES, Hanson ND, Black JA et al. Prevalence of newer β-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 2006; 44: 3318-24.
24. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5715-21.
25. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Standards Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
26. Schmidtke AJ, Hanson ND. Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistance. Antimicrob Agents Chemother 2006; 50: 2030-7.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001; 25: 402-8.
28. PulseNet: The National Molecular Subtyping Network for Foodborne Disease Surveillance. One-day (24-28 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed field gel electrophoresis (PFGE). 2004. http://www.cdc.gov/pulsenet/protocols/ecoli_salmonella_shigella_protocols.pdf (8 July 2011, date last accessed).
29. Sinnett D, Montpetit A. Isolation of cosmid and BAC DNA from E. coli. Methods Mol Biol 2003; 235: 99-102.
30. Sambrook J, Russell D. Molecular Cloning - A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
31. Gruber AR, Lorenz R, Bernhart SH et al. The Vienna RNA websuite. Nucleic Acids Res 2008; 36: W70-4.